Cardiovascular risk in chronic renal disease and transplantation prevention and management

Cardiovascular disease (CVD) is the single best predictor of mortality in patients with chronic kidney disease and in kidney transplant recipients. These populations are considered to be at extraordinarily high risk for CVD and its complications. On the other hand, renal dysfunction should be considered as a CVD risk factor. The management of CVD in patients with chronic kidney disease is a special challenge for clinicians. In this article, major risk factors for CVD are presented, as well as diagnosis of coronary artery disease, acute coronary syndromes, its treatment modalities (pharmacological therapy and coronary revascularisation procedures), and outcomes in patients with chronic renal failure and kidney allograft recipients.

[1]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[2]  R. Goldberg,et al.  Recent trends in hospital management practices and prognosis after acute myocardial infarction in patients with kidney disease. , 2004, The American journal of cardiology.

[3]  B. Davis,et al.  Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. , 2004, Journal of the American College of Cardiology.

[4]  W. Zidek,et al.  N-Acetylcysteine in nephrology; contrast nephropathy and beyond , 2004, Current opinion in nephrology and hypertension.

[5]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[6]  T. Stompór,et al.  Trends and dynamics of changes in calcification score over the 1-year observation period in patients on peritoneal dialysis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  J. Woo,et al.  Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. , 2004, Journal of the American Society of Nephrology : JASN.

[8]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[9]  R. Lauzurica,et al.  Adiponectin and Risk of New-Onset Diabetes Mellitus After Kidney Transplantation , 2004, Transplantation.

[10]  Suhail Ahmad.  HYPERTENSION IN HEMODIALYSIS PATIENTS: Dietary Sodium Restriction for Hypertension in Dialysis Patients , 2004, Seminars in dialysis.

[11]  A. Collins,et al.  Long-Term Outcome of Renal Transplant Recipients in the United States After Coronary Revascularization Procedures , 2004, Circulation.

[12]  L. Ruilope,et al.  Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients. , 2004, Journal of the American Society of Nephrology : JASN.

[13]  I. Holme,et al.  Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post‐Hoc Subgroup Analyses of the ALERT Study , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  Bruce Kupelnick,et al.  K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .

[15]  Deeb N Salem,et al.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.

[16]  F. Locatelli,et al.  Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  T. Villines,et al.  Cardiovascular risk in stage 4 and 5 nephropathy. , 2004, Advances in chronic kidney disease.

[18]  C. Gullion,et al.  Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. , 2004, Archives of internal medicine.

[19]  E. Ritz.  Managing mineral balance in end-stage renal disease. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  M. Yaqoob,et al.  Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  P. McCullough,et al.  Chronic Kidney Disease and Sudden Death: Strategies for Prevention , 2004, Blood Purification.

[22]  J. J. Griffin,et al.  Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction , 2003, Circulation.

[23]  L. Szczech,et al.  Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  M. Shlipak,et al.  Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. , 2003, Journal of the American Society of Nephrology : JASN.

[25]  B. Kiberd,et al.  Cardiovascular Disease Reduction in the Outpatient Kidney Transplant Clinic , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[27]  M. Schnitzler.  Diabetes Mellitus After Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  Allen J. Taylor,et al.  Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression. , 2003, Journal of the American Society of Nephrology : JASN.

[29]  Allen R Nissenson,et al.  Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. , 2003, The American journal of medicine.

[30]  B. Gersh,et al.  Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions. , 2003, American heart journal.

[31]  H. Krumholz,et al.  Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[32]  P. McCullough.  Acute coronary syndromes in patients with renal failure , 2003, Current cardiology reports.

[33]  P. Stenvinkel,et al.  Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. , 2003, Journal of the American Society of Nephrology : JASN.

[34]  R. Wolfe,et al.  The Report of a National Conference on the Wait List for Kidney Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  I. Holme,et al.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial , 2003, The Lancet.

[36]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[37]  C. Baigent,et al.  Study of Heart and Renal Protection (SHARP). , 2003, Kidney international. Supplement.

[38]  P. Golino,et al.  Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. , 2003, Journal of the American College of Cardiology.

[39]  H. Meier‐Kriesche,et al.  Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2 , 2003, Transplantation.

[40]  R. Foley,et al.  Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. , 2003, Kidney international.

[41]  S. Murphy.  THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Management of Heart Failure and Coronary Artery Disease in Patients with Chronic Kidney Disease , 2003 .

[42]  P. Aspelin,et al.  Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.

[43]  F. Sacks,et al.  Pravastatin for Secondary Prevention of Cardiovascular Events in Persons with Mild Chronic Renal Insufficiency , 2003, Annals of Internal Medicine.

[44]  W. Peacock,et al.  Cardiac troponins in renal insufficiency: review and clinical implications. , 2002, Journal of the American College of Cardiology.

[45]  H. Meier‐Kriesche,et al.  Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A Paired Donor Kidney Analysis1 , 2002, Transplantation.

[46]  R. Foley,et al.  Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. , 2002, Kidney international.

[47]  A. Collins,et al.  Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes , 2002, Circulation.

[48]  A. Jaffe,et al.  Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination , 2002, Annals of Internal Medicine.

[49]  M. Mcclellan,et al.  Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.

[50]  Hans L Hillege,et al.  Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.

[51]  M. Bahner,et al.  Advanced Coronary and Carotid Arteriopathy in Young Adults With Childhood-Onset Chronic Renal Failure , 2002, Circulation.

[52]  N. Powe,et al.  Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. , 2002, Journal of the American Society of Nephrology : JASN.

[53]  R. Califf,et al.  Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. , 2002, The New England journal of medicine.

[54]  R. Califf,et al.  Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation , 2002, Circulation.

[55]  G. Beck,et al.  Cardiovascular disease risk factors in chronic renal insufficiency. , 2002, Clinical nephrology.

[56]  K. Iseki,et al.  Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. , 2002, Kidney international.

[57]  R. Poveda,et al.  Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  A. Garg,et al.  Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. , 2002, Kidney international.

[59]  R. Foley,et al.  Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. , 2002, Journal of the American Society of Nephrology : JASN.

[60]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[61]  Jiang He,et al.  Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.

[62]  P. Raggi,et al.  Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? , 2002, Journal of the American College of Cardiology.

[63]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[64]  K. Iseki,et al.  Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. , 2002, Kidney international.

[65]  G. Angelini,et al.  Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency. , 2001, The Annals of thoracic surgery.

[66]  B. Kasiske,et al.  The evaluation of renal transplantation candidates: clinical practice guidelines. , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[67]  J. Blacher,et al.  Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease , 2001, Hypertension.

[68]  A. Pichard,et al.  The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with chronic renal failure. , 2001, Journal of the American College of Cardiology.

[69]  G. Chertow,et al.  Cardiac arrest and sudden death in dialysis units. , 2001, Kidney international.

[70]  R. Califf,et al.  Differential survival after coronary revascularization procedures among patients with renal insufficiency. , 2001, Kidney international.

[71]  P Langenberg,et al.  Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. , 2001, Archives of internal medicine.

[72]  J. Coresh,et al.  Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). , 2001, Archives of internal medicine.

[73]  S. Yusuf,et al.  Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.

[74]  A. Levin,et al.  Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[75]  F. Akçiçek,et al.  Strict volume control normalizes hypertension in peritoneal dialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[76]  P. Russo,et al.  Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial. , 2001, Journal of the American College of Cardiology.

[77]  A. Zanchetti,et al.  Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. , 2001, Journal of the American Society of Nephrology : JASN.

[78]  D. Baim,et al.  Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. , 2000, The American journal of cardiology.

[79]  B. Kasiske,et al.  Explained and unexplained ischemic heart disease risk after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[80]  A. Collins,et al.  Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[81]  R. Elashoff,et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.

[82]  B. Kasiske,et al.  Cardiovascular disease after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[83]  D. Levy,et al.  Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. , 1999, Kidney international.

[84]  K. Lynn,et al.  Ambulatory blood pressure monitoring in patients receiving long, slow home haemodialysis. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[85]  C. Herzog.  Acute myocardial infarction in patients with end-stage renal disease. , 1999, Kidney international. Supplement.

[86]  G. Russell,et al.  Sudden and cardiac death rates in hemodialysis patients. , 1999, Kidney international.

[87]  A. Levey,et al.  Epidemiology of Cardiac Disease in Dialysis Patients , 1999 .

[88]  R. Wolfe,et al.  Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[89]  R. Edelman,et al.  Diffusion-Weighted Magnetic Resonance Imaging in Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.

[90]  Mai-Szu Wu,et al.  Pre-Dialysis Glycemic Control is An Independent Predictor of Mortality Intype Ii Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[91]  A. Collins,et al.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. , 1998, The New England journal of medicine.

[92]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[93]  A. Levey,et al.  "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. , 1998, Kidney international.

[94]  R. Foley,et al.  Cardiac disease in the diabetic dialysis patient. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[95]  J. Zazgornik,et al.  Profile of antihypertensive drugs in hypertensive patients on renal replacement therapy (RRT). , 1997, Clinical nephrology.

[96]  A. Maggioni,et al.  Nephrologists neglect administration of betablockers to dialysed diabetic patients. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[97]  Mai-Szu Wu,et al.  Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[98]  M. Rocco,et al.  Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[99]  K. Malmberg.  Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.

[100]  F. Marumo,et al.  Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[101]  S. Kenny,et al.  Proteinuria and Mortality in Diabetes: the WHO Multinational Study of Vascular Disease in Diabetes , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[102]  O. Samuelsson,et al.  Lipoprotein metabolism and renal failure. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[103]  H. Feldman,et al.  Changes in causes of death after renal transplantation, 1966 to 1987. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[104]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[105]  M. Blaufox,et al.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.

[106]  B. Kasiske.  Risk factors for accelerated atherosclerosis in renal transplant recipients. , 1988, The American journal of medicine.

[107]  C. V. Strihou,et al.  Hypertension after renal transplantation. , 1976, British medical journal.

[108]  John F. Hurdle,et al.  Duration of end-stage renal disease and kidney transplant outcome. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[109]  R. Gansevoort,et al.  Electrocardiographic abnormalities and uremic cardiomyopathy. , 2005, Kidney international.

[110]  L. Bell,et al.  The American Society of Transplantation , 2005 .

[111]  M. Goicoechea,et al.  Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD). , 2005, Kidney international. Supplement.

[112]  B. Charra,et al.  Long thrice weekly hemodialysis: the Tassin experience. , 2004, The International journal of artificial organs.

[113]  R. Palomar,et al.  [Cardiovascular disease in kidney transplant recipients]. , 2004, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[114]  S. Murphy.  Management of heart failure and coronary artery disease in patients with chronic kidney disease. , 2003, Seminars in dialysis.

[115]  Deeb N Salem,et al.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.

[116]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .

[117]  European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[118]  R. Brant,et al.  Poor long-term survival after coronary angiography in patients with renal insufficiency. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[119]  A. Kocheril.  Arrhythmia issues in patients with renal disease. , 2001, Seminars in nephrology.

[120]  R. Gibey,et al.  Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. , 2000, Journal of the American Society of Nephrology : JASN.

[121]  Ebpg.  European Best Practice Guidelines for Renal Transplantation (part 1). , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[122]  J. Cameron,et al.  European best practice guidelines for the management of anaemia in patients with chronic renal failure. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[123]  L. Hunt,et al.  Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation. , 1997, Nephron.

[124]  Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. , 1997, JAMA.

[125]  Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. , 1995, Kidney international.

[126]  J. Curtis.  Hypertension after renal transplantation. , 1984, The Alabama journal of medical sciences.